Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
Influenza
2016
Americas
Clear all
Type of publications
NITAG documentation
(13)
Topics
Regions
Americas
(13)
Europe
(4)
Western Pacific
(1)
Countries
Canada
(2)
United States of America
(11)
Diseases
Influenza
(13)
Cholera
(3)
Dengue
(1)
Diphtheria
(4)
Hepatitis A
(1)
Japanese encephalitis
(2)
Meningococcal disease
(9)
Pneumococcal disease
(1)
Poliomyelitis
(1)
Rotavirus
(3)
Smallpox
(2)
Publication date
2016
(13)
2023
(2)
2022
(9)
2020
(4)
2019
(6)
2018
(7)
2017
(3)
2015
(8)
2014
(9)
2013
(1)
2012
(3)
2011
(2)
2010
(4)
2009
(6)
2008
(1)
2007
(1)
2006
(1)
Target population
Available to download in languages
English (EN)
(13)
French (FR)
(2)
13 results found
2016
∙
NACI
ADDENDUM - LAIV Use in Children and Adolescents
2016
∙
NACI
ADDENDUM - LAIV Use in Egg Allergic Individuals Advisory Committee Statement (ACS)
2016
∙
ACIP
Prevention and Control of Seasonal Influenza with Vaccines
2016
∙
Chris Ambrose
2015-16 US Influenza Vaccine Effectiveness Influenza Clinical Investigation for Children (ICICLE) Study
2016
∙
Tom Shimabukuro
End-of-Season Update: 2015-2016 Influenza Vaccine Safety Monitoring
2016
∙
J Mansi
FLUCELVAX QUADRIVALENT® (Influenza Vaccine) – ccIIV4
2016
∙
Bruce L Innis
Immunogenicity and Safety of GSK’s FluLaval™ Quadrivalent Inactivated Influenza Vaccine in Children 6-35 Months of Age
2016
∙
Wayne Hachey
Improved Efficacy of Recombinant Influenza Vaccine vs. Inactivated Vaccine During an Influenza Season Marked by a Vaccine Mismatch
2016
∙
Lynnette Brammer
Influenza Epidemiology and Surveillance Update
2016
∙
Brendan Flannery, Jessie Chung
Influenza Vaccine Effectiveness, Including LAIV vs IIV in Children and Adolescents, US Flu VE Network, 2015-16
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register